Scarica l'app Stockscreener
0.7838
3.11%
-0.0252
Dopo l'orario di chiusura:
.79
0.0062
+0.79%
Precedente Chiudi:
$0.809
Aprire:
$0.78
Volume 24 ore:
44,617
Relative Volume:
0.10
Capitalizzazione di mercato:
$7.75M
Reddito:
$3.95M
Utile/perdita netta:
$-14.59M
Rapporto P/E:
-0.6742
EPS:
-1.1626
Flusso di cassa netto:
$-14.46M
1 W Prestazione:
-4.41%
1M Prestazione:
-9.28%
6M Prestazione:
-30.02%
1 anno Prestazione:
-38.28%
Intervallo 1D:
$0.7704
$0.8089
Intervallo di 1 settimana:
$0.72
$0.9201
Portata 52W:
$0.72
$2.42
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
0.7838 | 7.75M | 3.95M | -14.59M | -14.46M | -1.1626 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-29 | Iniziato | Aegis Capital | Buy |
| 2020-12-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Iniziato | Oppenheimer | Outperform |
Evogene Ltd Borsa (EVGN) Ultime notizie
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance UK
Evogene receives Nasdaq notification - MSN
Evogene receives Nasdaq delisting warning over share price By Investing.com - Investing.com Canada
Evogene reports receipt of Nasdaq minimum bid price notification - MarketScreener
Evogene receives Nasdaq delisting warning over share price - Investing.com
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026 - TipRanks
Evogene Gets Nasdaq Minimum Bid Price Notification - MarketScreener
Nasdaq warns Evogene (NASDAQ: EVGN) over $1.00 minimum bid rule - Stock Titan
Nasdaq gives Evogene until Sept. 28 to fix its sub-$1 stock price - Stock Titan
Evogene stock soars after licensing deal for cancer therapeutic - Investing.com
Evogene Ltd Stock: Pioneering AI-Driven Plant Genomics for Sustainable Agriculture Markets - AD HOC NEWS
Casterra reports successful castor farming trials in Brazil By Investing.com - Investing.com South Africa
Evogene Ltd. (EVGN) Stock Price, News, Quote & History - Yahoo Finance
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock - Finviz
Casterra reports successful castor farming trials in Brazil - Investing.com
Evogene files for resale of 5.08M shares via warrant exercise - MSN
Brazil field trials show castor oil can scale as a biofuel feedstock - Stock Titan
EVGN SEC FilingsEvogene 10-K, 10-Q, 8-K Forms - Stock Titan
Chipmakers Recap: Will Evogene Ltd stock hit new highs in YEAREarnings Miss & Smart Allocation Stock Tips - baoquankhu1.vn
Market Recap: Is Evogene Ltd stock a hidden gemCEO Change & Precise Buy Zone Tips - baoquankhu1.vn
Evogene (NASDAQ: EVGN) resale registration for 5.08M ordinary shares - Stock Titan
Armistice selling up to 2.45M Evogene shares (NASDAQ: EVGN) - Stock Titan
Evogene Ltd Stock Faces Pressure Amid Biotech Sector Volatility and Pipeline Delays in 2026 - AD HOC NEWS
Evogene Earnings Call: AI Ambition Meets Cash Reality - TipRanks
If You Invested $1,000 in Evogene (EVGN) - Stock Titan
Evogene appoints Dr. Olga Nissan as vice president of business development to drive AI-driven growth - MSN
EVGN PE Ratio & Valuation, Is EVGN Overvalued - Intellectia AI
Evogene (EVGN) director Leon Recanati details share and option holdings - Stock Titan
Evogene (EVGN) director Nir details multiple stock option grants in Form 3 - Stock Titan
Evogene (EVGN) director details stock option grants and vesting - Stock Titan
Evogene (EVGN) chief development officer reports 40,000-share stock option grant - Stock Titan
[Form 3] Evogene Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Evogene (EVGN) director Sarit Firon details long-dated stock option grants - Stock Titan
Evogene (EVGN) CFO details RSU and stock option holdings - Stock Titan
Evogene (EVGN) CEO Haviv Ofer details multi-year stock option grants - Stock Titan
Evogene Ltd Stock (ISIN: IL0010831684) Faces Biotech Volatility Amid AI-Driven Crop Innovation Push - AD HOC NEWS
Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline By GuruFocus - Investing.com Canada
Evogene (EVGN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Evogene outlines ChemPass AI-driven strategy and anticipates new collaborations amid organizational realignment - MSN
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 - Sahm
How Evogene uses AI to design drugs, on show at BIO-Europe 2026 - Stock Titan
Evogene Ltd. (NASDAQ:EVGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Evogene Financial Results: Quarterly and Annual ReportNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Evogene Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
Evogene: Q4 Earnings Snapshot - theheraldreview.com
Evogene earnings missed by $0.20, revenue topped estimates - Investing.com Australia
Evogene Q4 2025 Earnings Call Transcript - MarketBeat
Why Did EVGN Shares Drop More Than 14% Today? - Stocktwits
Earnings call transcript: Evogene’s Q4 2025 highlights restructuring gains - Investing.com
Evogene Ltd Azioni (EVGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):